LIQT vs. PFE

Last updated Jun 3, 2026

LIQT (LiqTech International, Inc.) and PFE (Pfizer Inc.) are both stocks. LIQT operates in Pollution & Treatment Controls (Industrials), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, LIQT returned -25.71%/yr vs 1.94%/yr for PFE. At a 0.07 correlation, their price movements are largely independent.

Performance

LIQT vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LiqTech International, Inc. (LIQT) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LIQT achieves a -20.55% return, which is significantly lower than PFE's 6.05% return. Over the past 10 years, LIQT has underperformed PFE with an annualized return of -25.71%, while PFE has yielded a comparatively higher 1.94% annualized return.

LIQT

• 1D: 10.48%
• 1M: -47.51%
• YTD: -20.55%
• 6M: -37.30%
• 1Y: -30.95%
• 3Y*: -29.71%
• 5Y*: -53.88%
• 10Y*: -25.71%

PFE

• 1D: -0.31%
• 1M: -1.36%
• YTD: 6.05%
• 6M: 5.00%
• 1Y: 16.52%
• 3Y*: -7.06%
• 5Y*: -3.26%
• 10Y*: 1.94%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LIQT vs. PFE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LIQT LiqTech International, Inc.	-20.55%	-20.78%	-45.96%	12.17%	-93.36%	-28.50%	36.75%	6.75%	140.35%	-10.94%
PFE Pfizer Inc.	6.05%	0.65%	-2.22%	-41.26%	-10.41%	66.70%	3.07%	-6.91%	24.82%	15.90%

Correlation

The correlation between LIQT and PFE is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.05
Correlation (10Y) Calculated over the trailing 10-year period	0.09
Correlation (All Time) Calculated using the full available price history since Aug 14, 2012	0.07

Fundamentals

Market Cap LIQT : $11.42M PFE : $146.43B
EPS LIQT : -$0.92 PFE : $1.31
PS Ratio LIQT : 0.70 PFE : 2.30
PB Ratio LIQT : 1.50 PFE : 1.63
Total Revenue (TTM) LIQT : $16.03M PFE : $63.32B
Gross Profit (TTM) LIQT : $1.52M PFE : $43.91B
EBITDA (TTM) LIQT : -$5.85M PFE : $16.94B

Return for Risk

LIQT vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LIQT

LIQT Risk / Return Rank: 28
LIQT Sharpe Ratio Rank: 27
LIQT Sortino Ratio Rank: 34
LIQT Omega Ratio Rank: 34
LIQT Calmar Ratio Rank: 25
LIQT Martin Ratio Rank: 22

PFE

PFE Risk / Return Rank: 62
PFE Sharpe Ratio Rank: 63
PFE Sortino Ratio Rank: 58
PFE Omega Ratio Rank: 55
PFE Calmar Ratio Rank: 67
PFE Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LIQT vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LiqTech International, Inc. (LIQT) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LIQT	PFE	Difference
Sharpe ratio Return per unit of total volatility	-0.31	0.70	-1.00
Sortino ratio Return per unit of downside risk	0.20	1.20	-1.00
Omega ratio Gain probability vs. loss probability	1.02	1.14	-0.12
Calmar ratio Return relative to maximum drawdown	-0.45	1.43	-1.87
Martin ratio Return relative to average drawdown	-0.91	2.97	-3.88
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LIQT vs. PFE - Sharpe Ratio Comparison

The current LIQT Sharpe Ratio is -0.31, which is lower than the PFE Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of LIQT and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LIQT	PFE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.31	0.70	-1.00
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.70	-0.13	-0.58
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.33	0.08	-0.41
Sharpe Ratio (All Time) Calculated using the full available price history	-0.34	0.23	-0.58

Drawdowns

LIQT vs. PFE - Drawdown Comparison

The maximum LIQT drawdown since its inception was -99.27%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for LIQT and PFE.

Drawdown Indicators

	LIQT	PFE	Difference
Max Drawdown Largest peak-to-trough decline	-99.27%	-58.96%	-40.31%
Max Drawdown (1Y) Largest decline over 1 year	-64.53%	-11.47%	-53.06%
Max Drawdown (3Y) Largest decline over 3 years	-74.64%	-40.75%	-33.89%
Max Drawdown (5Y) Largest decline over 5 years	-98.37%	-58.96%	-39.41%
Max Drawdown (10Y) Largest decline over 10 years	-98.90%	-58.96%	-39.94%
Current Drawdown Current decline from peak	-99.19%	-47.05%	-52.14%
Average Drawdown Average peak-to-trough decline	-73.80%	-17.68%	-56.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.80%	5.51%	+26.29%

Volatility

LIQT vs. PFE - Volatility Comparison

LiqTech International, Inc. (LIQT) has a higher volatility of 41.92% compared to Pfizer Inc. (PFE) at 4.00%. This indicates that LIQT's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LIQT	PFE	Difference
Volatility (1M) Calculated over the trailing 1-month period	41.92%	4.00%	+37.92%
Volatility (6M) Calculated over the trailing 6-month period	79.87%	14.73%	+65.14%
Volatility (1Y) Calculated over the trailing 1-year period	101.25%	23.84%	+77.41%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	76.80%	25.49%	+51.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	77.69%	23.88%	+53.81%

Dividends

LIQT vs. PFE - Dividend Comparison

LIQT has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.73%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LIQT LiqTech International, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PFE Pfizer Inc.	6.73%	6.91%	6.33%	5.70%	3.12%	2.64%	3.92%	3.68%	3.12%	3.53%	3.69%	3.47%

Financials

LIQT vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between LiqTech International, Inc. and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LIQT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LiqTech International, Inc. reported a gross profit of 393.74K and revenue of 4.14M. Therefore, the gross margin over that period was 9.5%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.

LIQT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LiqTech International, Inc. reported an operating income of -2.28M and revenue of 4.14M, resulting in an operating margin of -55.1%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.

LIQT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LiqTech International, Inc. reported a net income of -2.71M and revenue of 4.14M, resulting in a net margin of -65.5%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.

Frequently Asked Questions

Can I hold both LIQT and PFE in my portfolio?

LIQT and PFE have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LIQT or PFE?

LIQT has higher volatility (41.92%) compared to PFE (4.00%). In terms of maximum drawdown, LIQT dropped -99.27% vs PFE's -58.96%.

Which has better risk-adjusted returns?

PFE currently has the higher Sharpe Ratio (0.70 vs -0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.